Zimmer Biomet Holdings Inc (ZBH) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Zimmer Biomet Holdings Inc   (NYSE: ZBH)


Zimmer Biomet Holdings Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Zimmer Biomet Holdings Inc's ROI in the second quarter of 2026?
Zimmer Biomet Holdings Inc achieved a return on average invested assets (ROI) of 3.97 % in its second quarter of 2026, which is below Zimmer Biomet Holdings Inc's average return on investment, which stands at 4.15%.

Despite the deterioration in its net income, company has improved ROI compared to the first quarter of 2026.

Within the Healthcare sector 148 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 1033 to 1774.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 5.34 % 9.02 % 10.89 % 9.13 % 3.72 %
Y / Y Net Income Change TTM -2.22 % -16.85 % -3.73 % 63.95 % 239.53 %
Investment (TTM) in Millions 19,793 19,866 20,516 21,095 20,175
Return On Investment (TTM) 3.97 % 3.73 % 3.45 % 4.03 % 4.28 %
ZBH's Overall Ranking # 1774 # 1033 # 1237 # 972 # 915
Seq. Investment Change TTM -0.47 % -0.04 % 1.99 % 3.81 % 3.01 %
Seq. Net Income Change TTM 6.07 % 7.9 % -12.65 % -2.19 % -9.8 %
Net Income (TTM) in Millions 807 761 705 807 825

ZBH Company Profile >> Back to ZBH Roi Comparisons >> See Annual ZBH Return On Investment



Return On Investment ZBH's Ranking
Within: No.
Industry # 47
Sector # 149
Overall # 1774

Return On Investment Statistics
High Average Low
10.71 %
4.15 %
-1.66 %
(Sep 30 2010)   (Jun 30 2019)







Financial Statements
Zimmer Biomet Holdings Inc's II. Quarter Investments $ 19,793 Millions ZBH's Balance sheet
Zimmer Biomet Holdings Inc's II. Quarter Income $ 200 Millions Quarterly ZBH's Income Statement
ZBH's Income by Division See ZBH's Income by Division


ZBH Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 20,516 18,923 18,647 18,715 19,994
Y / Y Investment Growth 8.42 % 1.48 % -0.36 % -6.4 % -8.56 %
Net Income in Millions 705 905 1,025 232 402
Y / Y Net Income Growth -22.1 % -11.69 % 341.09 % -42.2 % -
Annual Return On Investment 3.44 % 4.78 % 5.5 % 1.24 % 2.01 %


Annual Roi Comment
In the fiscal year 2025 ROI decreased relative to the previous year to 3.44 %, due to deterioration of net income.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ZBH's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ZBH's Competitors
Subscribers only: Roi for Zimmer Biomet Holdings Inc's Suppliers
Subscribers only: Return On Investment for ZBH's Customers

Other Ratios
ZBH's Roa ZBH's Inventory Turnover Ratio ZBH's Growth Rates ZBH's Dividend Statistics
ZBH's Profitability Ratios ZBH's Asset Turnover Ratio ZBH's Dividend Growth
ZBH's Roe ZBH's Valuation Ratios ZBH's Financial Strength Ratios ZBH's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI
National Healthcare Corp  10.91 %
Bioventus Inc   10.85 %
Infusystem Holdings Inc  10.53 %
Livanova Plc  10.40 %
Beone Medicines Ltd   10.32 %
Entrada Therapeutics Inc   10.15 %
Jazz Pharmaceuticals Plc  10.06 %
Prestige Consumer Healthcare Inc   10.06 %
Tactile Systems Technology Inc   10.02 %
Tenet Healthcare Corp  9.98 %
Nature s Sunshine Products inc   9.91 %
Boston Scientific Corporation  9.91 %
Align Technology inc   9.50 %
Pediatrix Medical Group Inc   9.18 %
Abbvie Inc   9.11 %
Ani Pharmaceuticals Inc  9.09 %
Viemed Healthcare Inc   8.97 %
Stryker Corp  8.80 %
Penumbra Inc  8.71 %
Utah Medical Products Inc  8.70 %
Edwards Lifesciences Corporation  8.39 %
Veracyte Inc   8.15 %
Phibro Animal Health Corporation  8.11 %
Brightspring Health Services Inc   8.05 %
Quest Diagnostics Inc  8.05 %
Addus Homecare Corp  7.98 %
Corcept Therapeutics Inc  7.96 %
Amneal Pharmaceuticals Inc   7.91 %
Concentra Group Holdings Parent Inc   7.89 %
Bio techne Corp  7.61 %

Date modified: 2026-09-11T09:47:04+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.